Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
C'Est Tout Studio is managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner and is located within 1 distinct art unit. This reflects a focused technical application within the biotech field. The use of 1 art unit suggests that the subject matter is specialized, requiring adherence to a specific set of technical guidelines and precedents.
COHEN, MICHAEL P is the busiest examiner for the portfolio, responsible for 1 pending office action. The company's current interaction with the patent office is limited to the review and feedback provided by this 1 examiner. Practitioners should prioritize understanding the examination history of COHEN, MICHAEL P to effectively navigate the requirements of the Biotechnology & Pharmaceuticals sector. This centralized approach ensures that the strategy remains focused on a single set of examiner expectations, which can simplify the management of the company's pending intellectual property.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| COHEN, MICHAEL P | 1 | 58.7% | +27.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18647613 | Tinted Deodorant Composition | COHEN, MICHAEL P | 12d |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18647613 | Tinted Deodorant Composition | COHEN, MICHAEL P | 1612 | §103 | Final Rejection | 12d | Pending | Apr 26, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial